Rescheduling marijuana to Schedule III marks a pivotal shift in federal drug policy by acknowledging its accepted medical use and moderate to low potential for dependence. This change promises tax relief, streamlined research, improved banking access, and clearer regulatory pathways for medical marijuana under the Controlled Substances Act. The rescheduling process involves scientific review, rulemaking, […]

The classification of marijuana, including its medical use, is a complex and often debated topic. In the United States, marijuana was classified as a Schedule I controlled substance in 1970 under the federal Controlled Substances Act and has stayed there for more than 50 years. With ongoing research and indications from anecdotal patient reports, there […]